Nuveen New York Select Tax-Free Income Portfolio (NYSE:NXN – Get Free Report) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 11,100 shares, a drop of 25.0% from the November 15th total of 14,800 shares. Based on an average trading volume of 9,000 shares, the days-to-cover ratio is presently 1.2 days.
Nuveen New York Select Tax-Free Income Portfolio Price Performance
NXN stock traded down $0.07 during mid-day trading on Friday, reaching $11.69. 12,726 shares of the company traded hands, compared to its average volume of 8,741. The firm’s 50 day moving average price is $11.95 and its 200 day moving average price is $11.86. Nuveen New York Select Tax-Free Income Portfolio has a fifty-two week low of $11.04 and a fifty-two week high of $12.40.
Nuveen New York Select Tax-Free Income Portfolio Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Tuesday, December 31st. Investors of record on Friday, December 13th will be given a dividend of $0.042 per share. The ex-dividend date is Friday, December 13th. This represents a $0.50 annualized dividend and a dividend yield of 4.31%.
Institutional Investors Weigh In On Nuveen New York Select Tax-Free Income Portfolio
About Nuveen New York Select Tax-Free Income Portfolio
Nuveen New York Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in the securities of companies that operate across diversified sectors.
Read More
- Five stocks we like better than Nuveen New York Select Tax-Free Income Portfolio
- 3 Stocks to Consider Buying in October
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to trade using analyst ratings
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Secondary Public Offering? What Investors Need to Know
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nuveen New York Select Tax-Free Income Portfolio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen New York Select Tax-Free Income Portfolio and related companies with MarketBeat.com's FREE daily email newsletter.